Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY

v3.22.4
CONSOLIDATED STATEMENTS OF CHANGE IN EQUITY - USD ($)
$ in Thousands
Common stock
January Offering
Common stock
Over Allotment January
Common stock
June Offering
Common stock
Over Allotment June
Common stock
Additional paid in capital
January Offering
Additional paid in capital
Over Allotment January
Additional paid in capital
June Offering
Additional paid in capital
Over Allotment June
Additional paid in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
January Offering
Over Allotment January
June Offering
Over Allotment June
Total
Balance at the beginning of the period, shares at Dec. 31, 2019         631,003,568                        
Balance at the beginning of the period at Dec. 31, 2019         $ 943         $ 585,623 $ (7,264) $ (455,664)         $ 123,638
Increase (Decrease) in Stockholders' Equity                                  
Issuance of shares upon exercise of stock options         $ 14         5,649             $ 5,663
Issuance of shares upon exercise of stock options (in shares)         11,401,390                       11,401,390
Issuance of common stock $ 165 $ 24 $ 155 $ 24   $ 78,451 $ 11,914 $ 209,831 $ 33,824       $ 78,616 $ 11,938 $ 209,986 $ 33,848  
Issue of common stock (in shares) 126,000,000 18,900,000 123,000,000 18,450,000                          
Other comprehensive loss                     (2,784)           $ (2,784)
Share-based compensation expense                   10,414             10,414
Net loss                       (130,092)         (130,092)
Balance at the end of the period at Dec. 31, 2020         $ 1,325         935,706 (10,048) (585,756)         341,227
Balance at the end of the period, shares at Dec. 31, 2020         928,754,958                        
Increase (Decrease) in Stockholders' Equity                                  
Issuance of shares upon exercise of stock options         $ 8         $ 751             $ 759
Issuance of shares upon exercise of stock options (in shares)         5,723,646                       5,723,646
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares)         3,069,330                        
Issue of shares under At The Market sales agreement, net of commission and expenses         4,000         2,525,000             2,529,000
Other comprehensive loss                     (1,094)           $ (1,094)
Share-based compensation expense                   $ 20,629             20,629
Net loss                       (158,090)         (158,090)
Balance at the end of the period at Dec. 31, 2021         $ 1,337         959,611 (11,142) (743,846)         $ 205,960
Balance at the end of the period, shares at Dec. 31, 2021         937,547,934                       928,547,934
Increase (Decrease) in Stockholders' Equity                                  
Issuance of shares upon exercise of stock options         $ 8         $ 42             $ 50
Issuance of shares upon exercise of stock options (in shares)         5,823,534                       5,823,534
Issue of shares under At The Market sales agreement, net of commission and expenses (in shares)         43,738,422                        
Issue of shares under At The Market sales agreement, net of commission and expenses         54,000         12,763,000             12,817,000
Other comprehensive loss                     10,267           $ 10,267
Share-based compensation expense                   $ 18,240             18,240
Net loss                       (165,456)         (165,456)
Balance at the end of the period at Dec. 31, 2022         $ 1,399         $ 990,656 $ (875) $ (909,302)         $ 81,878
Balance at the end of the period, shares at Dec. 31, 2022         987,109,890                       987,109,890